Implementation of an individualized argatroban protocol in an academic medical center

Bradley, Amber M.; Branan, Trisha
July 2011
American Journal of Health-System Pharmacy;7/15/2011, Vol. 68 Issue 14, p1292
Academic Journal
The article discusses the implementation of an individualized, weight-based protocol at the Medical College of Georgia for the use of argatroban in heparin-induced thrombocytopenia (HIT). Procedural facts related the same including formal guidelines, patient-specific argatroban dosing guide, and preparation for argatroban for intravenous (i.v.) administration are provided.


Related Articles

  • Anticoagulation.  // Indian Journal of Nephrology;Dec2012 Supplement, Vol. 22 Issue 7, pS22 

    The article states that anticoagulation is required to prevent clotting during a haemodialytic (HD) session as its absence may lead to blood loss and loss of dialyzer surface area. It also discusses the precautions to prevent dialyzer clotting and heparinization protocols including routine...

  • Working Toward a System-wide Venous Thromboembolism Prophylaxis Strategy: Experience From a Multisite Health Region. Semchuk, William; Kolodziejak, Lynette; Bubbar, Carolyn; Poulin, Susan // Hospital Pharmacy;Aug2011, Vol. 46 Issue 8, p574 

    Background: Venous thromboembolism (VTE), comprised of both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication for hospitalized patients. Clear guidance is available to practitioners in regard to risk factors for the development of VTE as well as strategies to...

  • Thanks a clot.  // Men's Health;May97, Vol. 12 Issue 4, p144 

    Provides information about an anticoagulant, clopidogrel's effectivity in preventing recurrences of heart attack and stroke. Advantage of clopidogrel compared to aspirin.

  • ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients.  // Best Practices for Hospital & Health-System Pharmacy;2014/2015, p527 

    The article presents a therapeutic position statement of the American Society of Health-System Pharmacists (ASHP), a professional association, on the role of pharmacotherapy in preventing venous thromboembolism (VTE) in hospital patients. Topics discussed include the burden of disease and...

  • VTE Prevention: Development of an Institutional Protocol and the Nurse’s Role. Tietze, Mari; Gurley, Jalandria // MEDSURG Nursing;Sep/Oct2014, Vol. 23 Issue 5, p331 

    Venous thromboembolism (VTE), including the combined diseases of deep vein thrombosis and pulmonary embolism, is a significant health problem that affects mortality, morbidity, and resource expenditure. Multiple guidelines have been formulated to address this condition, but broad implementation...

  • Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q). Prins, Martin H.; Marrel, Alexia; Carita, Paulo; Anderson, David; Bousser, Marie-Germaine; Crijns, Harry; Consoli, Silla; Arnould, Benoit // Health & Quality of Life Outcomes;2009, Vol. 7, p1 

    Background: The side effects and burden of anticoagulant treatments may contribute to poor compliance and consequently to treatment failure. A specific questionnaire is necessary to assess patients' needs and their perceptions of anticoagulant treatment. Methods: A conceptual model of...

  • Evidence lacking on anticoagulation therapy practices, guidelines say. Traynor, Kate // American Journal of Health-System Pharmacy;4/1/2012, Vol. 69 Issue 7, p538 

    The article reports the revised anticoagulation management guidelines from the American College of Chest Physicians (ACCP). Two strong recommendations of the guidelines include discontinuing routine pharmacogenetic testing to guide dosage decisions during warfarin or vitamin K antagonist...

  • Therapeutic control of anticoagulant treatment. Duxbury, B.McD. // British Medical Journal (Clinical Research Edition);3/6/1982, Vol. 284 Issue 6317, p702 

    Examines the therapeutic control of anticoagulant treatment in Great Britain. Effect on thromboplastin; Rarity of hemorrhage in British hospitals; Recommendation of higher ratio ranges for patients with open-heart surgery.

  • Managing Excessive Warfarin Anticoagulation. Bussey, Henry I. // Annals of Internal Medicine;9/18/2001, Vol. 135 Issue 6, p460 

    Editorial. Comments on the proper way of handling warfarin anticoagulation therapy. Failure to confirm the index international normalized ratio (INR) with repeated measurements; Estimation on the rate of decline of the INR after warfarin therapy; Decision to use vitamin K to reverse excessive...

  • Antidotes for patients taking novel oral anti-coagulants. Yip, Stefanie W.; Yiu Che Chan // World Journal of Emergency Medicine;2015, Vol. 6 Issue 4, p311 

    The article discusses the call for a clinical antidote to novel oral anti-coagulants (NOACs) including rivaroxaban, apixaban and edoxaban.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics